World Business Council For Sustainable Development (WBCSD), pharmaceutical business development.#Pharmaceutical #business #development

Posted On Feb 15 2018 by

pharmaceutical business development Stay on top of our latest news by subscribing to our Sustain newsletter World Business Council for Sustainable Development


Pharmaceutical Development: ICH, pharmaceutical development.#Pharmaceutical #development

Posted On Feb 9 2018 by

Pharmaceutical Development Finalised Guideline: The core tripartite harmonised ICH Guideline was finalised under Step 4 in November 2005. This Guideline is intended to provide guidance on the contents of Section 3.2.P.2 (Pharmaceutical Development) for drug products as defined in the scope of Module 3 of the Common Technical Document (ICH topic M4). The guideline does not apply to contents of submissions for drug products during the clinical research stages of drug development. However the principles in this guideline are important to consider during these stages. This guideline might also be appropriate for other types of products. To determine the applicability …


Pharmaceutical Drug Development Services, pharmaceutical development.#Pharmaceutical #development

Posted On Feb 9 2018 by

pharmaceutical development Experienced multi-disciplinary team providing flexible service options to deliver cost-effective and pragmatic development of pharmaceutical products to Phase 2b. S2PD supports clients in the following areas: Drug Development Planning Project Management S2PD has an experienced in-house drug development team to help clients with preclinical and early stage clinical phases. Our extensive experience in the space enables us to formulate plans and anticipate potential contingencies required. We know that work is often outsourced at short-notice with tight deliverable deadlines and sometimes with limited resources. S2PD will work with clients to define timelines, scope and resources required. Drug Candidate Selection …


UPM Pharmaceuticals – Formulation Development, CDMO, pharmaceutical formulation development.#Pharmaceutical #formulation #development

Posted On Jan 22 2018 by

pharmaceutical formulation development Proof of Concept Proof of Concept Proof of concept services at UPM are widely recognized for speed, precision and innovative thought across a full spectrum of studies. Based on our client needs, we evaluate a number of parameters for development and manufacture of specific API (active pharmaceutical ingredient) dosage forms based. Brevi-Batch is a cost effective development approach ideal for clients in search of high quality, proof of concept. With a significantly smaller scale than most small-scale R D formulation batches, Brevi-Batch conserves valuable R D API using equipment designed for fast set-up, use, and clean-up. UPM’s …


PHARMACEUTICAL BRAND NAMING, BRAND INSTITUTE, PRODUCT NAME DEVELOPMENT SERVICES, GLOBAL BRANDING, BRANDING CONSULTANTS LOS ANGELES, NEW YORK, TORONTO, TOKYO, pharmaceutical product development.#Pharmaceutical #product #development

Posted On Jan 21 2018 by

Welcome to Brand Institute. We name more products than anyone in the world! Recent Healthcare Approvals Brand ing Brand Institute is the world’s premier brand identity consultancy. Our brand agency portfolio of services includes brand strategy/architecture, name development, market research, regulatory and visual identity solutions.


Pharmaceutical Drug Development Services, pharmaceutical product development.#Pharmaceutical #product #development

Posted On Jan 21 2018 by

pharmaceutical product development Experienced multi-disciplinary team providing flexible service options to deliver cost-effective and pragmatic development of pharmaceutical products to Phase 2b. S2PD supports clients in the following areas: Drug Development Planning Project Management S2PD has an experienced in-house drug development team to help clients with preclinical and early stage clinical phases. Our extensive experience in the space enables us to formulate plans and anticipate potential contingencies required. We know that work is often outsourced at short-notice with tight deliverable deadlines and sometimes with limited resources. S2PD will work with clients to define timelines, scope and resources required. Drug Candidate …


Aspire Pharmaceuticals, pharma business development.#Pharma #business #development

Posted On Jan 17 2018 by

Welcome To Aspire Aspire Pharmaceuticals is a global leader in soft gelatin manufacturing. Our stringent procurement operations backed with rigorous analytics and testing infrastructure provides custom solutions for our clients from concept to delivery. We are here to guide our clients to innovate better all while optimizing their product journey. As industry trailblazers we are constantly looking to think beyond the status quo. About Us Our Mission As a leader in the development and manufacturing of soft gelatin nutritional supplements, we take that role with pride. Our singular vision starts with a question. How can we do it better? This …


Pharmaceutical Technology, pharmaceutical business development.#Pharmaceutical #business #development

Posted On Jan 10 2018 by

pharmaceutical business development Pharmaceutical Technology is using cookies We use them to give you the best experience. If you continue using our website, we’ll assume that you are happy to receive all cookies on this website. Log In Clinical Trials LIFNano: can nanotech ‘flip the switch’ to cure multiple sclerosis? Red sage: could this ancient Chinese herb prevent bone loss? Nutraceuticals are being held back by regulatory confusion Cold Chain Evocalcet faces stiff competition in Japan’s CKD-induced hyperparathyroidism market Blockchain in pharma: opportunities in the supply chain Are drug expiration dates fit for purpose? Diseases LIFNano: can nanotech ‘flip the …


PharmTech Home, pharmaceutical business development.#Pharmaceutical #business #development

Posted On Jan 10 2018 by

pharmaceutical business development Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases Using Human Challenge Trials to Develop Flu Vaccines Moving to Closed Systems for Aseptic Processing Cold Chain: Delivering Vaccines to Patients Accelerating Vaccine Development and Manufacturing Achieving Intensification and Flexibility in Virus Purification with N. Operational Best Practices Your Online Resource to Global Suppliers Top News EMA to Relocate to New HQ in Amsterdam in Wake of Brexit Nov 21, 2017 Following a vote by member states in favor of Amsterdam as the agency’s new headquarters, the relocation will take place over the next 16 months, with operations expected …


Research – Development News Channel #pharma #products

Posted On Jan 5 2018 by

#latest pharmaceutical news # Research Development News Channel Antibody reduces harmful brain amyloid plaques in Alzheimer’s patients Although the causes of Alzheimer’s disease are still unknown, it is clear that the disease commences with progressive amyloid deposition in the brains of affected persons between ten and fifteen years before the emergence of initial clinical symptoms such as memory loss. Researchers have now been able to show that Aducanumab, a human monoclonal antibody, selectively binds brain amyloid plaques, thus enabling microglial cells to remove the plaques. Last Updated: Saturday, 03 September 2016 Caffeine and its analogues revert memory deficits by normalizing …